Peripheral and metabolic effects of fenfluramine, 780SE, norfenfluramine and hydroxyethylnorfenfluramine--a review.
D000273:Adipose Tissue / Q000378:metabolism; D000662:Amphetamines / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D005277:Fenfluramine / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use; D005947:Glucose / Q000378:metabolism; D006168:Guinea Pigs; D006801:Humans; D050356:Lipid Metabolism; D009132:Muscles / Q000378:metabolism; D009642:Norfenfluramine / Q000031:analogs & derivatives / Q000494:pharmacology; D009765:Obesity / Q000188:drug therapy; D011817:Rabbits; D051381:Rats; D013329:Structure-Activity Relationship; D014280:Triglycerides / Q000097:blood
D000662:Amphetamines; D014280:Triglycerides; D009642:Norfenfluramine; D005277:Fenfluramine; D005947:Glucose